Literature DB >> 23461136

Toll-like receptors in liver disease.

Jan Petrasek1, Timea Csak, Gyongyi Szabo.   

Abstract

Activation of inflammatory signaling pathways is of central importance in the pathogenesis of alcoholic liver disease (ALD) and nonalcoholic steatohepatitis (NASH). Recent studies demonstrated that Toll-like receptors, the sensors of microbial and endogenous danger signals, are expressed and activated in innate immune cells as well as in parenchymal cells in the liver and thereby contribute to ALD and NASH. In this review, we emphasize the importance of gut-derived endotoxin and its recognition by TLR4 in the liver. The significance of TLR-induced intracellular signaling pathways and cytokine production as well as the contribution of individual cell types to the inflammation is evaluated. The contribution of TLR signaling to the induction of liver fibrosis and to the progression of liver pathology mediated by viral pathogens is reviewed in the context of ALD and NASH.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23461136     DOI: 10.1016/b978-0-12-405211-6.00006-1

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN: 0065-2423            Impact factor:   5.394


  36 in total

1.  Chalcone Derivative L6H21 Reduces EtOH + LPS-Induced Liver Injury Through Inhibition of NLRP3 Inflammasome Activation.

Authors:  Xiaoxia Kong; Guicheng Wu; Sha Chen; Lihua Zhang; Fengyuan Li; Tuo Shao; Li Ren; Shao-Yu Chen; Hongyu Zhang; Craig J McClain; Wenke Feng
Journal:  Alcohol Clin Exp Res       Date:  2019-06-30       Impact factor: 3.455

2.  Sparstolonin B (SsnB) attenuates liver fibrosis via a parallel conjugate pathway involving P53-P21 axis, TGF-beta signaling and focal adhesion that is TLR4 dependent.

Authors:  Diptadip Dattaroy; Ratanesh Kumar Seth; Sutapa Sarkar; Diana Kimono; Muayad Albadrani; Varun Chandrashekaran; Firas Al Hasson; Udai P Singh; Daping Fan; Mitzi Nagarkatti; Prakash Nagarkatti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Eur J Pharmacol       Date:  2018-09-05       Impact factor: 4.432

Review 3.  Novel insights in preventing Gram-negative bacterial infection in cirrhotic patients: review on the effects of GM-CSF in maintaining homeostasis of the immune system.

Authors:  Dong Xu; Manzhi Zhao; Yuhu Song; Jianxin Song; Yuancheng Huang; Junshuai Wang
Journal:  Hepatol Int       Date:  2014-11-21       Impact factor: 6.047

Review 4.  New insights into Nod-like receptors (NLRs) in liver diseases.

Authors:  Tao Xu; Yan Du; Xiu-Bin Fang; Hao Chen; Dan-Dan Zhou; Yang Wang; Lei Zhang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-03-10

5.  Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation.

Authors:  Diptadip Dattaroy; Ratanesh Kumar Seth; Suvarthi Das; Firas Alhasson; Varun Chandrashekaran; Gregory Michelotti; Daping Fan; Mitzi Nagarkatti; Prakash Nagarkatti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-12-30       Impact factor: 4.052

6.  Inhibition of IRAK4 kinase activity improves ethanol-induced liver injury in mice.

Authors:  Han Wang; Hao Zhou; Quanri Zhang; Kyle L Poulsen; Vanessa Taylor; Megan R McMullen; Doug Czarnecki; Dhweeja Dasarathy; Minjia Yu; Yun Liao; Daniela S Allende; Xing Chen; Lingzi Hong; Junjie Zhao; Jinbo Yang; Laura E Nagy; Xiaoxia Li
Journal:  J Hepatol       Date:  2020-07-16       Impact factor: 25.083

7.  Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease.

Authors:  Terence N Bukong; Arvin Iracheta-Vellve; Banishree Saha; Aditya Ambade; Abhishek Satishchandran; Benedek Gyongyosi; Patrick Lowe; Donna Catalano; Karen Kodys; Gyongyi Szabo
Journal:  Hepatology       Date:  2016-07-22       Impact factor: 17.425

8.  Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation.

Authors:  Francis M Hughes; Nivardo P Vivar; James G Kennis; Jeffery D Pratt-Thomas; Danielle W Lowe; Brooke E Shaner; Paul J Nietert; Laura S Spruill; J Todd Purves
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-27

Review 9.  Inflammasome activation and function in liver disease.

Authors:  Gyongyi Szabo; Jan Petrasek
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-09       Impact factor: 46.802

Review 10.  Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis.

Authors:  Jane Macnaughtan; Rajiv Jalan
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.